Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Encinitas, CA
SEC filing record 1 source field available
Fiscal year end
31 December
KIORA PHARMACEUTICALS INC has filed 917 SEC EDGAR filings since 09 Aug 2006

SEC filing history

Showing 601-625 of 911 matching filings.

Per page
25
Current page
25
FWP File 333-223887

FWP

Filing date
09 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-223887

AMENDMENT NO. 1 TO FORM S-1

Filing date
09 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-223887

FORM S-1

Filing date
23 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

FORM 8-K

Filing date
22 Mar 2018
Reporting date
20 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

8-K

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223431

S-8

Filing date
02 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

FORM 8-K

Filing date
26 Feb 2018
Reporting date
26 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88748

SC 13G/A filing

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

8-K

Filing date
12 Feb 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

FORM 8-K

Filing date
05 Feb 2018
Reporting date
05 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88748

SC 13D/A

Filing date
17 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88748

EYEGATE PHARMACEUTICALS, INC.

Filing date
16 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

8-K

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36672

FORM 8-K

Filing date
04 Jan 2018
Reporting date
01 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Jan 2018
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Jan 2018
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Jan 2018
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .